Staging Alzheimer's disease progression with multimodality neuroimaging.
about
Brain investigation and brain conceptualizationMultimodal neuroimaging computing: a review of the applications in neuropsychiatric disordersAmyloid positron emission tomography and cognitive reserveRobust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI dataThe clinical value of large neuroimaging data sets in Alzheimer's diseaseCognitive, emotional, and social benefits of regular musical activities in early dementia: randomized controlled study.Accent processing in dementia.The presenilin 1 P264L mutation presenting as non-fluent/agrammatic primary progressive aphasia.Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline.Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala's nucleus.Molecular brain imaging in the multimodality era.Integrating retrogenesis theory to Alzheimer's disease pathology: insight from DTI-TBSS investigation of the white matter microstructural integrity.Cross-View Neuroimage Pattern Analysis in Alzheimer's Disease Staging.Transcranial Direct Current Stimulation Modulates Cortical Neuronal Activity in Alzheimer's DiseaseInsulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's diseaseRelationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease.Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.Making the brain glow: in vivo bioluminescence imaging to study neurodegeneration.Pathomechanisms of atrophy in insular cortex in Alzheimer's disease.Multi-Kernel Learning with Dartel Improves Combined MRI-PET Classification of Alzheimer's Disease in AIBL Data: Group and Individual Analyses.Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease.A novel approach for integrative studies on neurodegenerative diseases in human brains.In vivo parahippocampal white matter pathology as a biomarker of disease progression to Alzheimer's disease.High thickness histological sections as alternative to study the three-dimensional microscopic human sub-cortical neuroanatomy.The Roots of Alzheimer's Disease: Are High-Expanding Cortical Areas Preferentially Targeted?†.Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer's Disease and Prediction of Cognitive Decline.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.
P2860
Q24604341-F007D54D-4CAD-4240-89EB-FCA43F925396Q26766362-5B274CF7-A185-4D7F-AFD6-DBCE287C96F7Q26769755-47DE9A99-BFC8-4FA6-A985-A3BE65FE8D5CQ28683731-F6D16A01-4D71-4F97-A888-A0D6B37E5A80Q28709465-84AD591A-F243-4DAA-85C8-C1F9EFB3DF88Q30353375-FCD3447F-1296-4F18-B196-42E983238AB4Q30461288-F168B024-B984-4630-9CB6-CA43CE9F37D7Q30579623-0044047D-9B25-4247-BAD8-782894F76868Q30680866-2FB54614-CFAB-47F2-8CC8-A37AE68DBA1FQ30870223-03DECE32-E0DC-4662-8D9B-A7C795F6001DQ30996727-4156F603-C012-4344-BC0E-BEAD35BAEDE6Q33862883-345D2108-A8E6-4807-A965-A08EBFAD67E6Q34204125-59A7A3CC-2D2C-4F65-8115-F31EE0B6E0F4Q34463023-93213B4C-B6A7-4DD3-94FA-1EDAA765B613Q36606287-AA04E434-B967-4CFF-8BF6-E27D07A5AC22Q36747740-38AF13B4-193B-480F-82E7-D5B02261F1C3Q37208538-71994470-D3EB-4136-B483-C8F4D4DD475CQ37217103-A3ED5D58-931A-4A98-968A-0226427D4CDBQ37721144-F5CA93B5-8B8D-4DFC-A9BD-5B57B9A4E004Q38063413-492C779A-9A8D-4345-AA37-7F6FBA2D525EQ38429584-090EECF2-E5BF-42C2-B0A2-7108EF21A02EQ38633079-C806193B-F994-4079-BBBC-ADFB7A4E133AQ38683925-FFA2BDC0-977F-4633-93F7-3AFBE7D018C3Q39419112-25ABA1D7-8B5B-40C1-A5C5-2820943B48E8Q42121704-CC29156C-3947-4AD7-8B48-FA3103EB5D0FQ45733857-52DE85E3-9BF7-4657-8A19-CEADAF2E043BQ45980363-437BFE41-2511-4574-9887-12FF08AEF85FQ46915612-7D664BD4-8103-4D6C-A886-D76F8598D7ECQ50131949-E22CE9D0-741B-4C0C-808F-DE4B89C7E0F2Q51760905-2AC97F80-D938-428F-9FAC-DCA5FBA212BE
P2860
Staging Alzheimer's disease progression with multimodality neuroimaging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Staging Alzheimer's disease progression with multimodality neuroimaging.
@en
Staging Alzheimer's disease progression with multimodality neuroimaging.
@nl
type
label
Staging Alzheimer's disease progression with multimodality neuroimaging.
@en
Staging Alzheimer's disease progression with multimodality neuroimaging.
@nl
prefLabel
Staging Alzheimer's disease progression with multimodality neuroimaging.
@en
Staging Alzheimer's disease progression with multimodality neuroimaging.
@nl
P2093
P2860
P50
P1476
Staging Alzheimer's disease progression with multimodality neuroimaging.
@en
P2093
Edson Amaro
Helmut Heinsen
Michael Ewers
P2860
P304
P356
10.1016/J.PNEUROBIO.2011.06.004
P577
2011-06-22T00:00:00Z